Navigation Links
PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
Date:6/17/2008

contains "forward-looking" statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "targets," and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks. Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2008 a
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting
2. PAREXEL Reaches Agreement To Acquire ClinPhone
3. PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference
4. PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
5. PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
6. PAREXEL Reports Third Quarter Fiscal Year 2008 Financial Results
7. PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference
8. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
9. PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France
10. PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call
11. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015 The Pistoia Alliance, a global, ... to lower barriers to innovation in R&D, has announced ... , The Ontologies Mapping project has been set up ... ontology management in life sciences R&D. The project will ... guidelines, tools and services to enable the universal application ...
(Date:4/28/2015)... 2015 uBiome, Inc. has announced ... provide clinical tests based on its unique microbial ... startup sparked the era of microbiome-based personalized medicine ... accessible information about their own bodies using the ... microbiome. uBiome has gathered millions of data points ...
(Date:4/28/2015)... More than 50% of patients with ... over the course of their disease, and clinicians are ... the disease progresses. ReachMD , the 24/7 health ... a series dedicated to PD psychosis, featuring interviews and ... and psychiatric conditions. , The new series titled ...
(Date:4/28/2015)... April 28, 2015 IMS is ... bring it to the web and provide greater ... user friendly reporting metrics increase data warehouse’s utility; ... convenient recall and access “on-the-go” makes data analysis ... using client feedback to assist in repository analytics ...
Breaking Biology Technology:Pistoia Alliance Announces Start of Ontologies Mapping Project 2uBiome Launches Clinical Laboratory 2ReachMD Launches Series Focusing on Parkinson’s Disease Psychosis 2
... Wis. Berbee Information Networks Corporation , a ... & Solutions LLC for an undisclosed sum. , ,Berbee said ... firm, bringing it to about 630 employees in all. Strategies ... IBM's iSeries line of business servers. , ,Berbee has ...
... new version of its Mediasite presentation recorder for the Japanese ... date and hopes to create a bigger market. , ,Mediasite ... as a PowerPoint deck with a video of the speaker ... , ,According to company statements the Japanese market is attractive ...
... Manufacturing Company in Racine is providing heat-transfer components ... , the company said on Wednesday. , ,The parts ... company's new hybrid vehicle. Modine's mass heat transfer ... which is the car's main energy source. , ,The ...
Cached Biology Technology:Modine explores making components for fuel cell vehicles 2Modine explores making components for fuel cell vehicles 3
(Date:4/27/2015)... ATLANTA , April 27, 2015  For more ... and trade show has been the premier worldwide event ... Systems 2015 is a must-attend event for any local, ... insight into the emerging commercial markets and current applications ... and innovations of this projected $48 billion industry, and ...
(Date:4/27/2015)... OXFORD, Conn. , Apr. 27, 2015 ... "Company"), a biometric authentication company focused on the growing ... will commence shipping to pre-order customers the first week ... pre-orders through the month of May. ... is a significant milestone for the company as Wocket® ...
(Date:4/27/2015)... 2015 Profile Solutions, Inc. (OTC: PSIQ), a ... is pleased to announce that Dr Gerry Bedore ... member of its scientific advisory board. ... thought leader in technology-enhanced learning models. He was a ... published studies and books focused on online student success ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... thrive in extreme situations---surviving on toxic chemicals, for instance. ... the American Chemical Society (JACS) May 25, University of ... that: by harnessing other potentially harmful chemicals known as ... , Such insights could lead to new ways of ...
... determined the first detailed molecular images of a piece of ... host cells and initiate the first stages of infection. The ... may help scientists learn new details about how the virus ... potential weak points that can be exploited by novel antiviral ...
... Albert Einstein College of Medicine have discovered a novel ... soon be able to resist the effects of antibiotics ... microbes, including Shigella and E. coli, are rapidly becoming ... led by Dr. John S. Blanchard, the Dan Danciger ...
Cached Biology News:A radical solution for environmental pollution 2Learning how SARS spikes its quarry 2Learning how SARS spikes its quarry 3Einstein researchers identify new way that bacteria develop resistance to antibiotics 2